Valuation: Ipca Laboratories Limited

Market Cap 451B 4.74B 4.14B 3.8B 3.55B 6.72B 6.84B 45.8B 17.75B 221B 17.8B 17.41B 763B P/E 2026
35.6x
P/E 2027 * 31.3x
Enterprise Value 446B 4.69B 4.1B 3.76B 3.51B 6.65B 6.76B 45.29B 17.55B 219B 17.6B 17.22B 754B EV / Sales 2026
4.24x
EV / Sales 2027 * 4.08x
Free-Float
54.92%
Yield 2026
0.37%
Yield 2027 * 0.34%
1 day+3.64%
1 week+10.09%
Current month+4.62%
1 month+18.14%
3 months+19.85%
6 months+26.87%
Current year+25.06%
1 week 1,605.35
Extreme 1605.35
1,787.9
1 month 1,530
Extreme 1530
1,787.9
Current year 1,392
Extreme 1392
1,787.9
1 year 1,252.95
Extreme 1252.95
1,787.9
3 years 743.05
Extreme 743.05
1,787.9
5 years 670
Extreme 670
1,787.9
10 years 200
Extreme 200
1,787.9
Manager TitleAgeSince
Chief Executive Officer 53 31/03/2023
Chief Executive Officer 70 31/03/2023
Chief Tech/Sci/R&D Officer 52 15/10/2023
Director TitleAgeSince
Chairman 79 04/07/2012
Director/Board Member 53 10/11/2008
Director/Board Member 70 31/07/1994
Change 5-day change 1-year change 3-year change Capi.($)
+3.64%+10.09% - - 4.58B
+3.45%+7.65%+55.77%+158.84% 1,082B
-1.16%+7.42%+69.09%+58.92% 633B
-0.77%+7.37%+36.87%+93.77% 461B
-0.35%+1.85%+31.30%+24.86% 339B
-0.45%+1.17%+41.96%+39.64% 301B
-0.08%+1.49%+32.40%+44.75% 292B
-1.54%+2.58%-25.52%-39.75% 225B
+3.55%+6.05%+26.04%+68.52% 202B
+0.40%+6.00%+17.72%+70.33% 163B
Average +1.70%+2.31%+31.74%+57.76% 411.08B
Weighted average by Cap. +1.38%+1.96%+42.23%+81.71%

Financials

2026 2027 *
Net sales 96.62B 1.01B 887M 814M 759M 1.44B 1.46B 9.8B 3.8B 47.39B 3.81B 3.73B 163B 108B 1.13B 989M 908M 847M 1.61B 1.63B 10.93B 4.24B 52.83B 4.25B 4.16B 182B
Net income 11.21B 118M 103M 94.46M 88.09M 167M 170M 1.14B 441M 5.5B 442M 432M 18.94B 14.04B 147M 129M 118M 110M 209M 213M 1.42B 552M 6.88B 554M 542M 23.72B
Net Debt -5.02B -52.7M -46.05M -42.29M -39.43M -74.76M -76.02M -509M -197M -2.46B -198M -194M -8.48B -11.82B -124M -109M -99.66M -92.94M -176M -179M -1.2B -465M -5.8B -466M -456M -19.98B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
16,778
Date Price Change Volume
03/07/26 1,780.90 +3.64% 18,090
02/07/26 ₹1,718.40 +1.29% 36,729
01/07/26 ₹1,696.45 -0.34% 72,201
30/06/26 ₹1,702.25 +3.26% 87,920
29/06/26 ₹1,648.45 +1.90% 12,650
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,719.40INR
Average target price
1,719.61INR
Spread / Average Target
+0.01%

Quarterly revenue - Rate of surprise